Overview

Morphine for Dyspnea in Pulmonary Fibrosis

Status:
Not yet recruiting
Trial end date:
2022-09-21
Target enrollment:
Participant gender:
Summary
"Determination of the effectiveness of nebulized morphine in the treatment of dyspnea in patients with advanced idiopathic pulmonary fibrosis"
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of Gdansk
Treatments:
Morphine